Target intelligence / Profile preview

TOM1L2 antisense RNA 1 (TOM1L2-AS1)

Target
TOM1L2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

TOM1L2 antisense RNA 1 (TOM1L2-AS1) is a long non-coding RNA transcribed from the antisense strand of the TOM1L2 gene region. Like many antisense lncRNAs, TOM1L2-AS1 is believed to function primarily in the regulation of gene expression, possibly by interacting with chromatin or modulating transcription and RNA stability. There is no evidence that TOM1L2-AS1 encodes a protein, nor is there current data linking it to specific biological pathways, disease phenotypes, or therapeutic interventions. Non-coding antisense RNAs have been implicated in diverse regulatory and epigenetic functions, but the specific roles of TOM1L2-AS1 have not been elucidated in the scientific literature[1][3][7]. Long non-coding antisense RNAs, such as TOM1L2-AS1, are increasingly recognized for their ability to regulate the expression of their sense counterpart genes and sometimes other pathways, often through mechanisms involving chromatin remodeling, transcriptional interference, or modulating RNA stability[3][4][7]. However, the field is still emerging and TOM1L2-AS1 has not been characterized in the context of disease nor as a direct target for drugs or therapeutic intervention[1].

Other names
TOM1L2-AS1TOM1L2 antisense RNA 1
02

Mechanism of action

None established for drugs, as TOM1L2-AS1 is not a recognized drug target

03

Biological functions

Regulation of gene expression (putative; common for antisense lncRNAs)Other
04

Disease associations

OtherNo directly associated disease roles reported for TOM1L2-AS1 itself
05

Safety considerations

None reported, as TOM1L2-AS1 is not in therapeutic use or targeted by drugs
06

Interacting drugs

None reported
07

Biomarkers

None reported for patient selection or efficacy

Beyond the preview

Go deeper on TOM1L2 antisense RNA 1 (TOM1L2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOM1L2 antisense RNA 1 (TOM1L2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call